EcoDrugPlus

Cyclin Dependent Kinase 1

Ensembl ID : ENSMZEG00005004857
Gene Symbol: CDK1
3 Cross references
246 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSMZEG00005022380
Gene Symbol: CDK2
3 Cross references
202 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSMZEG00005025020
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSMZEG00005007908
Gene Symbol: CDK6
3 Cross references
200 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSMZEG00005017161
Gene Symbol: CDK7
3 Cross references
218 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSMZEG00005000879
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cyclin-Dependent Kinase 4

Ensembl ID : ENSMZEG00005001344
Gene Symbol: LOC101475315
3 Cross references
238 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSMZEG00005006664
Gene Symbol: CYSLTR1
1 Cross references
172 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSMZEG00005026996
Gene Symbol: CDA
3 Cross references
200 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSMZEG00005009501
Gene Symbol: LOC101468649
3 Cross references
194 Possible Orthologues:

Cytochrome P450 3a30

Ensembl ID : ENSMZEG00005012231
Gene Symbol: LOC101471528
3 Cross references
474 Possible Orthologues:

Cytochrome P450 3a40

Ensembl ID : ENSMZEG00005019860
Gene Symbol: LOC101476786
2 Cross references
518 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).